ALNOV:EPA
Novacyt SA
0,44 €
arrow_downward
-1,12%(-0,0050) 1D
30 қаз., 15:26:21 GMT+1 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALNOV...
Open
0,44 €
High
0,44 €
Low
0,44 €
Mkt. cap
31,63 млн
Avg. vol.
195,23 м.
Volume
37,59 мың
52-wk high
1,04 €
52-wk low
0,29 €
EPS
-0,37 €
Shares outstanding
72,59 млн
No. of employees
228
Open
0,44 €
High
0,44 €
Low
0,44 €
Mkt. cap
31,63 млн
Avg. vol.
195,23 м.
Volume
37,59 мың
52-wk high
1,04 €
52-wk low
0,29 €
EPS
-0,37 €
Shares outstanding
72,59 млн
No. of employees
228
News stories
From web sources and news partners
Carbon Herald
·
26 минут бұрын
Nasdaq Launches New Carbon Issuance Calendar In Collaboration With Relae
Seeking Alpha
·
51 минут бұрын
Wall Street's bloodbath continues as tech trade drags markets after discouraging earnings reports
WFMZ.com
·
26 минут бұрын
Nasdaq most active stocks:
NBC News
·
1 сағат бұрын
Tech stocks set to wipe out more than $1 trillion as concerns deepen about the AI boom
Profile
Novacyt Group is an Anglo-French biotechnology group focused on clinical diagnostics, with offices in Camberley, Surrey, United Kingdom and Vélizy-Villacoublay, France. The company produces in vitro and molecular diagnostic tests, supplying assays and reagents worldwide. Its business units include Primerdesign, Microgen Bioproducts and Lab21 Healthcare.
In January 2020 the company announced that its molecular diagnostics division, Primerdesign, had launched a molecular test for the 2019 strain of SARSr-CoV. The test was approved as eligible for procurement under the World Health Organization's Emergency Use Listing process in April 2020, meaning that the test could be supplied by the United Nations and other procurement agencies supporting the COVID-19 response. In the same month Novacyt announced a collaboration with AstraZeneca, GlaxoSmithKline and the University of Cambridge to support the UK in its COVID-19 national screening programme at a new testing laboratory at the university's Anne McLaren laboratory. Wikipedia
About Novacyt SA